Shiloh
Editor, Senior Moderator
Source: https://jamanetwork.com/journals/jamapediatrics/fullarticle/2789353
February 21, 2022
Severity of Hospitalizations from SARS-CoV-2 vs Influenza and Respiratory Syncytial Virus Infection in Children Aged 5 to 11 Years in 11 US States
William Encinosa, PhD1; Jessica Figueroa, MS2; Youssef Elias, MD, PhD3
Author Affiliations Article Information
JAMA Pediatr. Published online February 21, 2022. doi:10.1001/jamapediatrics.2021.6566
In October 2021, the US Food and Drug Administration granted emergency use authorization for the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine to be used in children aged 5 to 11 years to reduce costly hospitalizations. By that time, for children in this age group, there had been 1.8 million people diagnosed with SARS-CoV-2 infection and 143 deaths, with more than 8000 hospitalizations.1 However, very little is known about the severity of these hospitalizations relative to the 2 most common childhood viruses, the influenza virus and respiratory syncytial virus (RSV), which resemble the SARS-CoV-2 virus. In this study, we compared the January through March 2021 hospitalizations of children aged 5 to 11 years who were diagnosed with SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C; a sequela of COVID-19 disease)2 with those hospitalizations of children aged 5 to 11 years infected with influenza and RSV...
February 21, 2022
Severity of Hospitalizations from SARS-CoV-2 vs Influenza and Respiratory Syncytial Virus Infection in Children Aged 5 to 11 Years in 11 US States
William Encinosa, PhD1; Jessica Figueroa, MS2; Youssef Elias, MD, PhD3
Author Affiliations Article Information
JAMA Pediatr. Published online February 21, 2022. doi:10.1001/jamapediatrics.2021.6566
In October 2021, the US Food and Drug Administration granted emergency use authorization for the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine to be used in children aged 5 to 11 years to reduce costly hospitalizations. By that time, for children in this age group, there had been 1.8 million people diagnosed with SARS-CoV-2 infection and 143 deaths, with more than 8000 hospitalizations.1 However, very little is known about the severity of these hospitalizations relative to the 2 most common childhood viruses, the influenza virus and respiratory syncytial virus (RSV), which resemble the SARS-CoV-2 virus. In this study, we compared the January through March 2021 hospitalizations of children aged 5 to 11 years who were diagnosed with SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C; a sequela of COVID-19 disease)2 with those hospitalizations of children aged 5 to 11 years infected with influenza and RSV...